In a corner of a technical research university campus in Lausanne, Nestlé SA scientists are untangling genetic profiles to develop medical foods—one of the company’s big hopes for sales growth.
These aren’t the high-energy protein bars that people buy over the counter before a workout. Instead, the Swiss food company is tapping into an estimated $15 billion market for prescription-based powders and drinks intended to meet specific nutritional requirements to treat diseases.
Read Full Article »